financetom
Business
financetom
/
Business
/
Bandhan Bank Q2 profit down 5% at Rs 920 cr
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bandhan Bank Q2 profit down 5% at Rs 920 cr
Nov 2, 2020 6:16 AM

Bandhan Bank on Monday reported 5.3 percent decline in net profit at Rs 920 crore for September quarter of the current fiscal year. The bank clocked a net profit of Rs 971.80 crore in the same period of 2019-20.

Total income grew 22 percent to Rs 2,304.90 crore in July-September 2020-21 as against Rs 1,889.30 crore in the year-ago period, Bandhan Bank said in a regulatory filing. Net interest income of the Kolkata-headquartered lender jumped 25.8 percent to Rs 1,923.1 crore during the quarter while the non-interest income grew 6.1 percent to Rs 381.8 crore.

Bandhan Bank said it has reported the highest ever quarterly profit before tax at Rs 1,233 crore during the period under review. Net Interest Margin (annualised) in the quarter fell to 8 percent against 8.2 percent in year-ago period. During the quarter, the bank took accelerated additional provision on standard advances amounting to Rs 300 crore. With this provision and the additional standard assets provision that bank is carrying in micro banking portfolio, the total additional provision in books stands at Rs 2,096 crore, it said.

The bank’s gross non-performing assets fell to 1.2 percent (Rs 874 crore) of gross advances as of September 30, 2020 as against 1.8 percent (Rs 1,064.20 crore) by the year-ago same period. Net NPAs too improved to 0.4 percent (Rs 262.50 crore) from 0.6 percent (Rs 336.90 crore).

”As the moratorium ended on 31st August 2020 coupled with robust rural performance, we have seen an all-round improvement in collection, disbursement and deposits. On deposits front, we have witnessed the best ever quarter whereas on the disbursement front, we are close to pre-COVID-19 level.”

Collections have seen a steady improvement month-on-month and is expected to reach near normal in the next 90 days. We now look forward to accelerate the business in H2FY 21,” Managing Director and CEO Chandra Shekhar Ghosh said. Total Advances grew 19.4 percent to Rs 76,614.6 crore as on September 30, 2020. Total deposits increased 34.4 percent to Rs 66,127.7 crore.

Bandhan Bank stock was trading at Rs 305.50 on BSE, up 5.62 percent from the previous close.

First Published:Nov 2, 2020 3:16 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Toymaker Hasbro's turnaround efforts help Q1 profit beat, ease sales decline
Toymaker Hasbro's turnaround efforts help Q1 profit beat, ease sales decline
Apr 24, 2024
(Reuters) -Hasbro ( HAS ) reported a smaller-than-expected drop in first-quarter sales and easily beat profit estimates on Wednesday, as leaner inventories and steady digital gaming revenue helped cushion a drag from softer demand for toys. Shares of the company, up roughly 14% this year, rose about 4% in premarket trading. The Play-Doh maker has grappled with weakening demand over...
Humana beats first-quarter profit estimates on strength of Medicare business
Humana beats first-quarter profit estimates on strength of Medicare business
Apr 24, 2024
April 24 (Reuters) - Humana beat first-quarter profit expectations on Wednesday, helped by strength in its government-backed Medicare Advantage insurance business for older adults. On an adjusted basis, Humana reported a profit of $7.23 per share, higher than the average analyst estimate of $6.12 per share, according to LSEG data. (Reporting by Mariam Sunny and Leroy Leo in Bengaluru; Editing...
Thermo Fisher's Fiscal Q1 Adjusted Earnings Rise While Revenue Falls; Fiscal 2024 Outlook Updated -- Shares Advance Pre-Bell
Thermo Fisher's Fiscal Q1 Adjusted Earnings Rise While Revenue Falls; Fiscal 2024 Outlook Updated -- Shares Advance Pre-Bell
Apr 24, 2024
06:46 AM EDT, 04/24/2024 (MT Newswires) -- Thermo Fisher Scientific ( TMO ) reported fiscal Q1 adjusted earnings Wednesday of $5.11 per diluted share, up from $5.03 a year earlier. Analysts polled by Capital IQ expected $4.71. Revenue for the quarter ended March 30 was $10.34 billion, down from $10.71 billion a year earlier. Analysts surveyed by Capital IQ expected...
Biogen beats quarterly profit estimates, Alzheimer's drug sales jump
Biogen beats quarterly profit estimates, Alzheimer's drug sales jump
Apr 24, 2024
April 24 (Reuters) - Biogen beat Wall Street estimates for first-quarter profit on Wednesday, helped by a series of cost-cutting measures as older drugs face fierce competition. The company also said its Alzheimer's drug Leqembi, developed with Japanese partner Eisai ( ESALF ), recorded global sales of about $19 million, nearly tripling from the fourth quarter of 2023. The number...
Copyright 2023-2026 - www.financetom.com All Rights Reserved